People's Hospital of Tibet Autonomous Region
Damxung, Tibet, 850000, China
NCT Number: NCT03270787
This study is to evaluate the efficacy and safety of compound danshen dripping pills in preventing and treating acute mountain sickness.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Phase 1 / Phase 2
Damxung, Tibet, 850000, China
Compound danshen dripping pills is mainly used for the treatment and prevention of coronary heart disease and high-risk groups ,consists of Danshen (Radix Salviae Miltiorrhizae), Sanqi (Radix Notoginseng) and borneol.Danshen is the main drug efficacy of stasis, nourishing the nerves.Pharmacological studies have shown that Danshen can improve the oxygen carrying capacity of blood, increase oxygen supply to vital organs, effectively reduce hypoxia-induced heart and other vital organs, brain and kidney damage. Danshen can activate the fibrinolytic system, reduce blood viscosity, clear the microcirculation, promote blood circulation, increasing the amount of tissue oxygen by inhibiting platelet aggregation.This study is being conducted to evaluate the efficacy and safety of compound danshen dripping pills in preventing and treating acute mountain sickness, when compared with placebo.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Drug: Placebo Placebo,10pills,tid,treat 1 weeks.
Drug: Compound danshen dripping pills Compound danshen dripping pills,10pills,tid,treat 1 weeks.
Time frame: 7days
Tasly Pharmaceuticals, Inc.
Industry
A Randomized, Double Blind, Placebo-controlled Study of Compound Danshen Dripping Pills in Preventing and Treating Acute Mountain Sickness
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06499714
Acute Mountain Sickness, Altitude Sickness
Bishkek, Kyrgyzstan
View Trial DetailsNCT06499727
Acute Mountain Sickness, Altitude Sickness
Bishkek, Kyrgyzstan
View Trial DetailsNCT06393998
Acute Mountain Sickness, Altitude Sickness
Guangzhou, Guangdong, China
View Trial DetailsNCT06450899
Acute Mountain Sickness, Altitude Sickness
Evergreen, Colorado, United States
View Trial Details